News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,501 Results
Type
Article (41336)
Company Profile (283)
Press Release (681872)
Multimedia
Podcasts (83)
Webinars (17)
Section
Business (205151)
Career Advice (2022)
Deals (35623)
Drug Delivery (111)
Drug Development (81725)
Employer Resources (173)
FDA (16458)
Job Trends (14965)
News (347268)
Policy (32777)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2572)
Accelerated approval (31)
Adcomms (24)
Allergies (142)
Alliances (49735)
ALS (170)
Alzheimer's disease (1665)
Antibody-drug conjugate (ADC) (311)
Approvals (16719)
Artificial intelligence (511)
Autoimmune disease (172)
Automation (38)
Bankruptcy (361)
Best Places to Work (11655)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (189)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (633)
Cancer (4790)
Cardiovascular disease (398)
Career advice (1707)
Career pathing (35)
CAR-T (289)
CDC (45)
Celiac Disease (2)
Cell therapy (752)
Cervical cancer (36)
Clinical research (69817)
Collaboration (1702)
Company closure (4)
Compensation (1152)
Complete response letters (54)
COVID-19 (2718)
CRISPR (88)
C-suite (834)
Cystic fibrosis (143)
Data (6214)
Decentralized trials (2)
Denatured (25)
Depression (132)
Diabetes (500)
Diagnostics (6693)
Digital health (47)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (253)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (230)
Earnings (90217)
Editorial (55)
Employer branding (21)
Employer resources (152)
Events (117668)
Executive appointments (971)
FDA (19564)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1467)
Gene editing (197)
Generative AI (43)
Gene therapy (594)
GLP-1 (966)
Government (4670)
Grass and pollen (6)
Guidances (383)
Healthcare (18932)
HIV (58)
Huntington's disease (44)
IgA nephropathy (82)
Immunology and inflammation (265)
Immuno-oncology (57)
Indications (108)
Infectious disease (2980)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (245)
Interviews (315)
IPO (16679)
IRA (49)
Job creations (3647)
Job search strategy (1427)
JPM (57)
Kidney cancer (15)
Labor market (83)
Layoffs (549)
Leadership (30)
Legal (7953)
Liver cancer (91)
Longevity (14)
Lung cancer (645)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (792)
MASH (164)
Medical device (13761)
Medtech (13814)
Mergers & acquisitions (20004)
Metabolic disorders (1265)
Multiple sclerosis (162)
NASH (17)
Neurodegenerative disease (314)
Neuropsychiatric disorders (89)
Neuroscience (2891)
Neurotech (1)
NextGen: Class of 2026 (6549)
Non-profit (4516)
Now hiring (66)
Obesity (592)
Opinion (262)
Ovarian cancer (166)
Pain (197)
Pancreatic cancer (224)
Parkinson's disease (279)
Partnered (33)
Patents (489)
Patient recruitment (482)
Peanut (57)
People (58995)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (21768)
Phase 2 (30762)
Phase 3 (22858)
Pipeline (5218)
Policy (279)
Postmarket research (2569)
Preclinical (9245)
Press Release (64)
Prostate cancer (236)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (833)
Real estate (5965)
Recruiting (70)
Regulatory (24514)
Reports (52)
Research institute (2410)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (147)
Series A (240)
Series B (192)
Service/supplier (11)
Sickle cell disease (98)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3644)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (56)
Vaccines (996)
Venture capital (87)
Weight loss (379)
Women's health (89)
Worklife (18)
Date
Today (134)
Last 7 days (646)
Last 30 days (2222)
Last 365 days (30058)
2026 (3187)
2025 (30305)
2024 (35361)
2023 (40176)
2022 (51319)
2021 (55887)
2020 (54236)
2019 (46656)
2018 (35102)
2017 (32198)
2016 (31596)
2015 (37655)
2014 (31392)
2013 (26431)
2012 (28648)
2011 (29348)
2010 (27413)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (39439)
Australia (6452)
California (11250)
Canada (3269)
China (1113)
Colorado (476)
Connecticut (472)
Delaware (333)
Europe (85266)
Florida (1673)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (857)
India (64)
Indiana (517)
Iowa (22)
Japan (424)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1381)
Massachusetts (8087)
Michigan (321)
Minnesota (623)
Mississippi (5)
Missouri (128)
Montana (35)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2990)
New Mexico (28)
New York (2959)
North Carolina (1449)
North Dakota (8)
Northern California (5489)
Ohio (331)
Oklahoma (21)
Oregon (44)
Pennsylvania (2272)
Puerto Rico (24)
Rhode Island (47)
South America (1112)
South Carolina (65)
South Dakota (1)
Southern California (4368)
Tennessee (174)
Texas (1736)
United States (39910)
Utah (334)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (933)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
723,501 Results for "autoimmune inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical testing, is focused on B cell–driven autoimmune diseases.
February 9, 2026
·
2 min read
·
Dan Samorodnitsky
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
The partners have yet to disclose what their priority indications are, though EVOQ’s NanoDisc technology aims to enable the development of potentially curative treatments for autoimmune conditions such as celiac disease and type 1 diabetes.
October 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Evaxion expands AI-Immunology™ platform into autoimmune diseases
January 13, 2026
·
4 min read
Layoffs
Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset
Kezar Life Sciences suffered multiple clinical holds and four patient deaths in a trial testing zetomipzomib for lupus—a program that has since been canned. The company is still pursuing development in autoimmune hepatitis, but recent FDA communications could delay its timeline.
November 10, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
December 23, 2025
·
2 min read
Press Releases
Autoimmunity BioSolutions Bolsters Leadership Team
November 20, 2025
·
4 min read
Press Releases
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
January 9, 2026
·
5 min read
Press Releases
Kincell Bio Announces Partnership with RegCell to Advance Treg Cell Therapies into Clinical Trials for Autoimmune Diseases
February 10, 2026
·
4 min read
Autoimmune disease
Amgen Ends Autoimmune Alliance With Kyowa Kirin Amid Safety, Efficacy Questions
A Phase III readout in September 2024 for rocatinlimab, on which Amgen and Kyowa Kirin were collaborating in atopic dermatitis, appeared underwhelming to analysts, with Jefferies noting that the data “came in at the lower end of efficacy and expectations.”
February 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Formation Bio Licenses miR-124 Activator for Autoimmune Diseases from CTFH
January 30, 2026
·
3 min read
1 of 72,351
Next
